Works matching IS 03065251 AND DT 2011 AND VI 72 AND IP 2

Results: 23

SB-656933, a novel CXCR2 selective antagonist, inhibits ex vivo neutrophil activation and ozone-induced airway inflammation in humans.

Published in:

British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 282, doi. 10.1111/j.1365-2125.2011.03968.x

By:

Lazaar, Aili L.;
Sweeney, Lisa E.;
MacDonald, Alexander J.;
Alexis, Neil E.;
Chao Chen;
Tal-Singer, Ruth

Publication type:

Article

Systemic bioavailability of hydrofluoroalkane formulations containing fluticasone and salmeterol: a reply.

Published in:

British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 355, doi. 10.1111/j.1365-2125.2011.03979.x

By:

Lipworth, Brian J.;
Clearie, Karine L.

Publication type:

Article

Effects of the moderate CYP3A4 inhibitor, fluconazole, on the pharmacokinetics of fesoterodine in healthy subjects.

Published in:

British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 263, doi. 10.1111/j.1365-2125.2011.04007.x

By:

Malhotra, Bimal;
Dickins, Maurice;
Alvey, Christine;
Jumadilova, Zhanna;
Xiaoxi Li;
Duczynski, Gregory;
Gandelman, Kuan

Publication type:

Article

Population pharmacokinetic analysis of sorafenib in patients with solid tumours.

Published in:

British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 294, doi. 10.1111/j.1365-2125.2011.03963.x

By:

Jain, Lokesh;
Woo, Sukyung;
Gardner, Erin R.;
Dahut, William L.;
Kohn, Elise C.;
Kummar, Shivaani;
Mould, Diane R.;
Giaccone, Giuseppe;
Yarchoan, Robert;
Venitz, Jürgen;
Figg, William D.

Publication type:

Article

Important details to be clarified about the effect of rectal ozone on the portal vein oxygenation.

Published in:

British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 350, doi. 10.1111/j.1365-2125.2011.03974.x

By:

Bocci, Velio;
Zanardi, Iacopo;
Travagli, Valter

Publication type:

Article

Cardiac effects of muscarinic receptor antagonists used for voiding dysfunction.

Published in:

British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 186, doi. 10.1111/j.1365-2125.2010.03813.x

By:

Andersson, Karl-Erik;
Campeau, Lysanne;
Olshansky, Brian

Publication type:

Article

Pilot of a National Inpatient Medication Chart in Australia: improving prescribing safety and enabling prescribing training.

Published in:

British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 338, doi. 10.1111/j.1365-2125.2011.03967.x

By:

Coombes, Ian D.;
Reid, Carol;
McDougall, David;
Stowasser, Danielle;
Duiguid, Margaret;
Mitchell, Charles

Publication type:

Article

Systemic bioavailability of hydrofluoroalkane formulations containing fluticasone propionate and salmeterol.

Published in:

British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 353, doi. 10.1111/j.1365-2125.2011.03978.x

By:

Daley-Yates, Peter T.;
Parkins, David A.

Publication type:

Article

Clinical pharmacology of functional disorders of the urogenital system.

Published in:

2011

By:

Michel, Martin C.

Publication type:

Editorial

Effects of fesoterodine on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers.

Published in:

British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 257, doi. 10.1111/j.1365-2125.2011.03989.x

By:

Malhotra, Bimal;
Alvey, Christine;
Gong, Jason;
Xiaoxi Li;
Duczynski, Gregory;
Gandelman, Kuan

Publication type:

Article

Phosphodiesterase (PDE) inhibitors in the treatment of lower urinary tract dysfunction.

Published in:

British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 197, doi. 10.1111/j.1365-2125.2010.03828.x

By:

Ückert, Stefan;
Oelke, Matthias

Publication type:

Article

Translation Section.

Published in:: 2011
Publication type:: Other

α<sub>1</sub>-Adrenoceptors and muscarinic receptors in voiding function - binding characteristics of therapeutic agents in relation to the pharmacokinetics.

Published in:

British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 205, doi. 10.1111/j.1365-2125.2011.03922.x

By:

Yamada, Shizuo;
Ito, Yoshihiko;
Tsukada, Hideo

Publication type:

Article

Omalizumab decreases IgE production in patients with allergic (IgE-mediated) asthma; PKPD analysis of a biomarker, total IgE.

Published in:

British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 306, doi. 10.1111/j.1365-2125.2011.03962.x

By:

Lowe, Philip J.;
Renard, Didier

Publication type:

Article

Important details to be clarified about the effect of rectal ozone on the portal vein oxygenation.

Published in:

British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 352, doi. 10.1111/j.1365-2125.2011.03973.x

By:

Zaky, Saad;
Kotb, Hassan;
Fouad, Ehab

Publication type:

Article

Tamsulosin shows a higher unbound drug fraction in human prostate than in plasma: a basis for uroselectivity?

Published in:

British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 218, doi. 10.1111/j.1365-2125.2010.03870.x

By:

Korstanje, Cees;
Krauwinkel, Walter;
van Doesum-Wolters, Francisca L. C.

Publication type:

Article

Deaths of opiate/opioid misusers involving dihydrocodeine, UK, 1997-2007.

Published in:

British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 330, doi. 10.1111/j.1365-2125.2011.03908.x

By:

Zamparutti, Giuliano;
Schifano, Fabrizio;
Corkery, John M.;
Oyefeso, Adenekan;
Ghodse, A. Hamid

Publication type:

Article

Comparison of pharmacokinetic variability of fesoterodine vs. tolterodine extended release in cytochrome P450 2D6 extensive and poor metabolizers.

Published in:

British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 226, doi. 10.1111/j.1365-2125.2011.03948.x

By:

Malhotra, Bimal;
Darsey, Edress;
Crownover, Penelope;
Fang, Juanzhi;
Glue, Paul

Publication type:

Article

Effects of strong CYP2D6 and 3A4 inhibitors, paroxetine and ketoconazole, on the pharmacokinetics and cardiovascular safety of tamsulosin.

Published in:

British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 247, doi. 10.1111/j.1365-2125.2011.03988.x

By:

Troost, Joachim;
Tatami, Shinji;
Tsuda, Yasuhiro;
Mattheus, Michaela;
Mehlburger, Ludwig;
Wein, Martina;
Michel, Martin C.

Publication type:

Article

Erratum.

Published in:: 2011
Publication type:: Erratum

A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder.

Published in:

British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 235, doi. 10.1111/j.1365-2125.2011.03961.x

By:

Callegari, Ernesto;
Malhotra, Bimal;
Bungay, Peter J.;
Webster, Rob;
Fenner, Katherine S.;
Kempshall, Sarah;
LaPerle, Jennifer L.;
Michel, Martin C.;
Kay, Gary G.

Publication type:

Article

Eltrombopag increases plasma rosuvastatin exposure in healthy volunteers.

Published in:

British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 321, doi. 10.1111/j.1365-2125.2011.03972.x

By:

Allred, Alicia J.;
Bowen, Carolyn J.;
Jung Wook Park;
Bin Peng;
Williams, Daphne D.;
Wire, Mary Beth;
Lee, Edmund

Publication type:

Article

Pharmacokinetics, pharmacodynamics and safety of a human anti-IL-6 monoclonal antibody (sirukumab) in healthy subjects in a first-in-human study.

Published in:

British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 270, doi. 10.1111/j.1365-2125.2011.03964.x

By:

Zhenhua Xu;
Bouman-Thio, Esther;
Comisar, Craig;
Frederick, Bart;
Van Hartingsveldt, Bart;
Marini, Joseph C.;
Davis, Hugh M.;
Honghui Zhou

Publication type:

Article